Literature DB >> 21720467

Hypertension in cancer patients.

Elie Mouhayar1, Abdulla Salahudeen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21720467      PMCID: PMC3113122     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


× No keyword cloud information.
  10 in total

1.  Receptor tyrosine kinase inhibition, hypertension, and proteinuria: is endothelin the smoking gun?

Authors:  Neeraj Dhaun; David J Webb
Journal:  Hypertension       Date:  2010-08-23       Impact factor: 10.190

2.  Sorafenib in advanced clear-cell renal-cell carcinoma.

Authors:  Bernard Escudier; Tim Eisen; Walter M Stadler; Cezary Szczylik; Stéphane Oudard; Michael Siebels; Sylvie Negrier; Christine Chevreau; Ewa Solska; Apurva A Desai; Frédéric Rolland; Tomasz Demkow; Thomas E Hutson; Martin Gore; Scott Freeman; Brian Schwartz; Minghua Shan; Ronit Simantov; Ronald M Bukowski
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

Review 3.  Four faces of baroreflex failure: hypertensive crisis, volatile hypertension, orthostatic tachycardia, and malignant vagotonia.

Authors:  Terry Ketch; Italo Biaggioni; RoseMarie Robertson; David Robertson
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

Review 4.  Molecular basis of hypertension side effects induced by sunitinib.

Authors:  Guadalupe Aparicio-Gallego; Francisco J Afonso-Afonso; Luis León-Mateos; Jose L Fírvida-Pérez; Sergio Vázquez-Estévez; Martín Lázaro-Quintela; Manuel Ramos-Vázquez; Ovidio Fernández-Calvo; Begoña Campos-Balea; Luis M Antón-Aparicio
Journal:  Anticancer Drugs       Date:  2011-01       Impact factor: 2.248

5.  Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.

Authors:  M T Meinardi; J A Gietema; W T van der Graaf; D J van Veldhuisen; M A Runne; W J Sluiter; E G de Vries; P B Willemse; N H Mulder; M P van den Berg; H S Koops; D T Sleijfer
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

6.  Isradipine for the prevention of cyclosporine-induced hypertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study.

Authors:  M Bursztyn; O Zelig; R Or; A Nagler
Journal:  Transplantation       Date:  1997-04-15       Impact factor: 4.939

7.  Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors.

Authors:  Michael L Maitland; George L Bakris; Henry R Black; Helen X Chen; Jean-Bernard Durand; William J Elliott; S Percy Ivy; Carl V Leier; Joann Lindenfeld; Glenn Liu; Scot C Remick; Richard Steingart; W H Wilson Tang
Journal:  J Natl Cancer Inst       Date:  2010-03-29       Impact factor: 13.506

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  VEGF inhibition and renal thrombotic microangiopathy.

Authors:  Vera Eremina; J Ashley Jefferson; Jolanta Kowalewska; Howard Hochster; Mark Haas; Joseph Weisstuch; Catherine Richardson; Jeffrey B Kopp; M Golam Kabir; Peter H Backx; Hans-Peter Gerber; Napoleone Ferrara; Laura Barisoni; Charles E Alpers; Susan E Quaggin
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

10.  Prognostic importance of comorbidity in a hospital-based cancer registry.

Authors:  Jay F Piccirillo; Ryan M Tierney; Irene Costas; Lori Grove; Edward L Spitznagel
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

  10 in total
  30 in total

Review 1.  Managing cardiac risk factors in oncology clinical trials.

Authors:  Apostolia-Maria Tsimberidou; Giorgio Minotti; Daniela Cardinale
Journal:  Tex Heart Inst J       Date:  2011

2.  Non-pharmacological interventions in patients with spinal cord compression: a systematic review.

Authors:  María Paniagua-Collado; Omar Cauli
Journal:  J Neurooncol       Date:  2017-11-20       Impact factor: 4.130

3.  Associations between physical activity and comorbidities in Korean cancer survivors.

Authors:  Dong-Woo Kang; Eun-Young Lee; Ki Yong An; Jihee Min; Justin Y Jeon; Kerry S Courneya
Journal:  J Cancer Surviv       Date:  2018-03-01       Impact factor: 4.442

4.  Use of Antihypertensive Medications and Survival Rates for Breast, Colorectal, Lung, or Stomach Cancer.

Authors:  Yong Cui; Wanqing Wen; Tao Zheng; Honglan Li; Yu-Tang Gao; Hui Cai; Mingrong You; Jing Gao; Gong Yang; Wei Zheng; Yong-Bing Xiang; Xiao-Ou Shu
Journal:  Am J Epidemiol       Date:  2019-08-01       Impact factor: 4.897

5.  Calcium-channel-blockers exhibit divergent regulation of cancer extravasation through the mechanical properties of cancer cells and underlying vascular endothelial cells.

Authors:  S R Vaibavi; Manoj Sivasubramaniapandian; Rahul Vaippully; Privita Edwina; Basudev Roy; Saumendra Kumar Bajpai
Journal:  Cell Biochem Biophys       Date:  2021-10-13       Impact factor: 2.194

6.  Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women.

Authors:  Mildren A Del-Sueldo; María A Mendonça-Rivera; Martha B Sánchez-Zambrano; Judith Zilberman; Ana G Múnera-Echeverri; María Paniagua; Lourdes Campos-Alcántara; Claudia Almonte; Amalia Paix-Gonzales; Claudia V Anchique-Santos; Claudine J Coronel; Gabriela Castillo; María G Parra-Machuca; Ivanna Duro; Paola Varletta; Patricia Delgado; Verónica I Volberg; Adriana C Puente-Barragán; Adriana Rodríguez; Aida Rotta-Rotta; Anabela Fernández; Ana C Izeta-Gutiérrez; Ana E Ancona-Vadillo; Analía Aquieri; Andrea Corrales; Andrea Simeone; Bibiana Rubilar; Carolina Artucio; Carolina Pimentel-Fernández; Celi Marques-Santos; Clara Saldarriaga; Christian Chávez; Cristina Cáceres; Dahiana Ibarrola; Daniela Barranco; Edison Muñoz-Ortiz; Edith D Ruiz-Gastelum; Eduardo Bianco; Elena Murguía; Enrique Soto; Fabiola Rodríguez-Caballero; Fanny Otiniano-Costa; Giovanna Valentino; Iris B Rodríguez-Cermeño; Ivan R Rivera; Jairo A Gándara-Ricardo; Jesús A Velásquez-Penagos; Judith Torales; Karina Scavenius; Karen Dueñas-Criado; Laura García; Laura Roballo; Lucía R Kazelian; Macarena Coussirat-Liendo; María C Costa-Almeida; Mariana Drever; Mariela Lujambio; Marildes L Castro; Maritza Rodríguez-Sifuentes; Mónica Acevedo; Mónica Giambruno; Mónica Ramírez; Nancy Gómez; Narcisa Gutiérrez-Castillo; Onelia Greatty; Paola Harwicz; Patricia Notaro; Rocío Falcón; Rosario López; Sady Montefilpo; Sara Ramírez-Flores; Silvina Verdugo; Soledad Murguía; Sonia Constantini; Thais C Vieira; Virginia Michelis; César M Serra
Journal:  Arch Cardiol Mex       Date:  2022

Review 7.  Clinically Relevant Physical Benefits of Exercise Interventions in Breast Cancer Survivors.

Authors:  Amy A Kirkham; Kelcey A Bland; Sarah Sayyari; Kristin L Campbell; Margot K Davis
Journal:  Curr Oncol Rep       Date:  2016-02       Impact factor: 5.075

Review 8.  Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.

Authors:  Ronald G Schwartz; Diwakar Jain; Eugene Storozynsky
Journal:  J Nucl Cardiol       Date:  2013-06       Impact factor: 5.952

9.  Hypertensive nephropathy and cancer: Is it the hypertension, the nephropathy, or both?

Authors:  Sabine Karam
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-05-24       Impact factor: 3.738

10.  Direct left-ventricular global longitudinal strain (GLS) computation with a fully convolutional network.

Authors:  Julia Kar; Michael V Cohen; Samuel A McQuiston; Teja Poorsala; Christopher M Malozzi
Journal:  J Biomech       Date:  2021-11-27       Impact factor: 2.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.